Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationLeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)
Ratios

Relay Therapeutics (RLAY) Receivables - Net (2020 - 2023)

Relay Therapeutics (RLAY) has disclosed Receivables - Net for 4 consecutive years, with $211000.0 as the latest value for Q3 2023.

  • Quarterly Receivables - Net fell 12.45% to $211000.0 in Q3 2023 from the year-ago period, while the trailing twelve-month figure was $211000.0 through Sep 2023, down 12.45% year-over-year, with the annual reading at $306000.0 for FY2022, 24.07% down from the prior year.
  • Receivables - Net for Q3 2023 was $211000.0 at Relay Therapeutics, up from $78000.0 in the prior quarter.
  • The five-year high for Receivables - Net was $75.0 million in Q4 2020, with the low at $78000.0 in Q2 2023.
  • Average Receivables - Net over 4 years is $7.1 million, with a median of $286000.0 recorded in 2023.
  • The sharpest move saw Receivables - Net tumbled 99.46% in 2021, then grew 6.32% in 2023.
  • Over 4 years, Receivables - Net stood at $75.0 million in 2020, then crashed by 99.46% to $403000.0 in 2021, then decreased by 24.07% to $306000.0 in 2022, then plummeted by 31.05% to $211000.0 in 2023.
  • According to Business Quant data, Receivables - Net over the past three periods came in at $211000.0, $78000.0, and $286000.0 for Q3 2023, Q2 2023, and Q1 2023 respectively.